These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 2961850

  • 1. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
    Herrick-Davis K, Titeler M.
    J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
    [Abstract] [Full Text] [Related]

  • 2. [3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
    Nelson DL, Monroe PJ, Lambert G, Yamamura HI.
    Life Sci; 1987 Sep 28; 41(13):1567-76. PubMed ID: 2957559
    [Abstract] [Full Text] [Related]

  • 3. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
    Rydelek-Fitzgerald L, Teitler M, Fletcher PW, Ismaiel AM, Glennon RA.
    Brain Res; 1990 Nov 05; 532(1-2):191-6. PubMed ID: 2282513
    [Abstract] [Full Text] [Related]

  • 4. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB, Miquel MC, Gozlan H, Hamon M.
    J Neurochem; 1991 May 05; 56(5):1705-16. PubMed ID: 1826520
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
    Nénonéné EK, Radja F, Carli M, Grondin L, Reader TA.
    J Neurochem; 1994 May 05; 62(5):1822-34. PubMed ID: 8158133
    [Abstract] [Full Text] [Related]

  • 6. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A, Verrièle L, Chaput C, Millan MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 05; 357(3):205-17. PubMed ID: 9550290
    [Abstract] [Full Text] [Related]

  • 7. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
    Harrington MA, Peroutka SJ.
    J Neurochem; 1990 Jan 05; 54(1):294-9. PubMed ID: 2136705
    [Abstract] [Full Text] [Related]

  • 8. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB, Battaglia G, Creese I.
    Mol Pharmacol; 1985 Dec 05; 28(6):487-94. PubMed ID: 2867462
    [Abstract] [Full Text] [Related]

  • 9. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
    Hashimoto T, Nishino N, Nakai H, Tanaka C.
    Life Sci; 1991 Dec 05; 48(4):355-63. PubMed ID: 1824956
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of 3H-agonist binding to pre- and postsynaptic 5-HT1A receptors in bovine brain.
    Iben LG, Mahle CD, Yocca FD.
    Br J Pharmacol; 1994 Dec 05; 113(4):1400-6. PubMed ID: 7889298
    [Abstract] [Full Text] [Related]

  • 11. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR, Peroutka SJ.
    Biochem Pharmacol; 1986 Jun 15; 35(12):1943-9. PubMed ID: 3013203
    [Abstract] [Full Text] [Related]

  • 12. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X, Ennis C, Minchin MC.
    Life Sci; 1997 Jan 16; 60(9):653-65. PubMed ID: 9048968
    [Abstract] [Full Text] [Related]

  • 14. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
    Barrett JE, Hoffmann SM, Olmstead SN, Foust MJ, Harrod C, Weissman BA.
    Psychopharmacology (Berl); 1989 Jan 16; 97(3):319-25. PubMed ID: 2524083
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological and biochemical characterization of rat hippocampal 5-hydroxytryptamine1A receptors solubilized by 3-[3-(cholamidopropyl)dimethylammonio]-1-propane sulfonate (CHAPS).
    el Mestikawy S, Cognard C, Gozlan H, Hamon M.
    J Neurochem; 1988 Oct 16; 51(4):1031-40. PubMed ID: 2971097
    [Abstract] [Full Text] [Related]

  • 16. Photoaffinity labelling and solubilization on the central 5-HT1A receptor binding site.
    Gozlan H, Emerit MB, el Mestikawy S, Cossery JM, Marquet A, Besselievre R, Hamon M.
    J Recept Res; 1987 Oct 16; 7(1-4):195-221. PubMed ID: 2957498
    [Abstract] [Full Text] [Related]

  • 17. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
    Hall MD, Gozlan H, Emerit MB, el Mestikawy S, Pichat L, Hamon M.
    Neurochem Res; 1986 Jun 16; 11(6):891-912. PubMed ID: 3016581
    [Abstract] [Full Text] [Related]

  • 18. Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins.
    Emerit MB, el Mestikawy S, Gozlan H, Rouot B, Hamon M.
    Biochem Pharmacol; 1990 Jan 01; 39(1):7-18. PubMed ID: 2136995
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors.
    Kirchgessner AL, Liu MT, Howard MJ, Gershon MD.
    J Comp Neurol; 1993 Jan 08; 327(2):233-50. PubMed ID: 8425944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.